Thus, IRF-1 signaling may also be implicated in progression and aggravation of inflammatory bowel diseases by supporting the accumulation of dysregulated NCR+ ILCs, which has been reported in the inflamed gut mucosa in CD43,44. This evidence concerns the gene SPN and inflammatory bowel disease.